Latest Insider Transactions at Madrigal Pharmaceuticals, Inc. (MDGL)
This section provides a real-time view of insider transactions for Madrigal Pharmaceuticals, Inc. (MDGL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MADRIGAL PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MADRIGAL PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 23
2022
|
Remy Sukhija Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-27.87%
|
$8,250,000
$275.27 P/Share
|
Dec 23
2022
|
Remy Sukhija Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$1,800,000
$60.26 P/Share
|
Dec 23
2022
|
Brian Joseph Lynch SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
7,000
-26.86%
|
$1,925,000
$275.28 P/Share
|
Dec 23
2022
|
Brian Joseph Lynch SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$637,000
$91.79 P/Share
|
Dec 03
2021
|
Fred B Craves |
SELL
Other acquisition or disposition
|
Indirect |
824,172
-76.08%
|
-
|
Dec 03
2021
|
Bay City Capital LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
24,172
-95.04%
|
-
|
Dec 03
2021
|
Bay City Capital LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
800,000
-66.59%
|
-
|
Dec 01
2020
|
Bay City Capital LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
43,537
-1.85%
|
-
|